U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 076043
Company: TARO

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
TERCONAZOLE TERCONAZOLE 0.4% CREAM;VAGINAL Prescription AB No Yes

Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
01/19/2005 ORIG-1 Approval

Label is not available on this site.
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
08/20/2015 SUPPL-9 Labeling-Package Insert

Label is not available on this site.
08/20/2015 SUPPL-8 Labeling-Package Insert

Label is not available on this site.

TERCONAZOLE

CREAM;VAGINAL; 0.4%
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
TERCONAZOLE TERCONAZOLE 0.4% CREAM;VAGINAL Prescription No AB 076712 FOUGERA PHARMS
TERCONAZOLE TERCONAZOLE 0.4% CREAM;VAGINAL Prescription No AB 076043 TARO
Back to Top